After running four months after the completion of the $7.4B merger, INC Research and inVentiv Health finally rename themselves Syneos Health. The company will be traded […]

The biggest health-care investing conference of the year is over, but the ideas discussed will continue to unfold. Here are three major themes from the J.P. […]

Biopharma Dive predicts that the drug pricing debate will stay in the headlines in 2018, and that mergers and acquisitions could get a jumpstart after Congress […]

BioSpace presents its NextGen Bio “Class of 2018,” a list of 20 promising life science companies in North America that started up no earlier than 2015. […]

In December 2017, the Food and Drug Administration (FDA) revealed its 2018 goals, reflecting Commissioner Scott Gottlieb’s priorities. The FDA’s 2018 strategic policy roadmap highlights the […]

Novartis is preparing to auction off its U.S. generic pill business, which has struggled amid fierce price competition, unlike the fortunes of the rest of Novartis’ […]

Fast Company recently published The World’s 50 Most Innovative Companies 2018, topping off its edition of the top 350 most innovative companies. See which life science […]

Amazon has quietly launched an exclusive line of over-the-counter health products called Basic Care in a possible challenge to pharmacy retail chains. The line includes 60 […]

FiercePharma analyzed productivity at major pharma and biotech companies by measuring revenue per employee in 2016 (the most recent numbers available), and they found a winning […]